• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

高CFP评分表明局部晚期直肠癌(LARC)患者预后不良且对放化疗反应不佳。

High CFP score indicates poor prognosis and chemoradiotherapy response in LARC patients.

作者信息

Lu Siyi, Liu Zhenzhen, Wang Bingyan, Li Fei, Meng Yan, Wang Junwei, Wang Yuxia, Wang Hao, Zhou Xin, Fu Wei

机构信息

Department of General Surgery, Peking University Third Hospital, Beijing, 100191, China.

Department of Radiotherapy, Peking University Third Hospital, Beijing, 100191, China.

出版信息

Cancer Cell Int. 2021 Apr 13;21(1):205. doi: 10.1186/s12935-021-01903-1.

DOI:10.1186/s12935-021-01903-1
PMID:33849545
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8045186/
Abstract

BACKGROUND

Preoperative tumor markers, inflammation, and nutritional status are considered important predictors of prognosis and tumor response in locally advanced rectal cancer (LARC) patients. This study aims to explore the prognostic and predictive role of carcinoembryonic antigen (CEA), the Fibrinogen-Albumin Ratio Index (FARI), the Prognostic Nutritional Index (PNI) in LARC patients and compared them with a novel combined CEA-FARI-PNI (CFP) scoring system.

METHODS

A total of 138 LARC patients undergoing radical surgery following neoadjuvant chemoradiotherapy (NCRT) between January 2012 and March 2019 were enrolled. The X-tile program was used to determine the optimal cut-off values of CEA, FARI, and PNI, and CFP scoring system was constructed accordingly. The prognostic ability of these factors was assessed by the time-dependent receiver operating characteristic (ROC) curve, Kaplan-Meier, Cox regression, and logistic regression. Nomogram was established to evaluate the predictive role of these factors in tumor response.

RESULTS

The optimal cut-off values of CEA, FARI, and PNI were 5.15 ng/l, 10.56%, and 42.25 g/L, respectively. The time-dependent ROC curve showed that compared to CEA, FARI, and PNI, CFP showed stable predictive efficacy for overall survival (OS) and disease-free survival (DFS). In multivariate analysis, CFP was the only factor that could independently predict OS (HR = 8.117, p = 0.001) and DFS (HR = 4.994, p < 0.001). Moreover, high CFP (OR = 3.693, p = 0.002) was also an independent risk factor of poor response. The area under the ROC curve (AUC) of the nomograms for predicting tumor response was better including CFP (0.717) than without CFP (0.656) (p < 0.05).

CONCLUSIONS

The CFP score was a more reliable marker for predicting OS, DFS, and NCRT efficacy in LARC patients, and the score could apparently improve predicted efficacy of the nomogram.

摘要

背景

术前肿瘤标志物、炎症和营养状况被认为是局部晚期直肠癌(LARC)患者预后和肿瘤反应的重要预测指标。本研究旨在探讨癌胚抗原(CEA)、纤维蛋白原-白蛋白比率指数(FARI)、预后营养指数(PNI)在LARC患者中的预后和预测作用,并将它们与一种新的CEA-FARI-PNI(CFP)联合评分系统进行比较。

方法

纳入2012年1月至2019年3月期间138例接受新辅助放化疗(NCRT)后行根治性手术的LARC患者。使用X-tile程序确定CEA、FARI和PNI的最佳临界值,并据此构建CFP评分系统。通过时间依赖性受试者操作特征(ROC)曲线、Kaplan-Meier法、Cox回归和逻辑回归评估这些因素的预后能力。建立列线图以评估这些因素在肿瘤反应中的预测作用。

结果

CEA、FARI和PNI的最佳临界值分别为5.15 ng/l、10.56%和42.25 g/L。时间依赖性ROC曲线显示,与CEA、FARI和PNI相比,CFP对总生存期(OS)和无病生存期(DFS)具有稳定的预测效能。在多变量分析中,CFP是唯一能够独立预测OS(HR = 8.117,p = 0.001)和DFS(HR = 4.994,p < 0.001)的因素。此外,高CFP(OR = 3.693,p = 0.002)也是反应不佳的独立危险因素。预测肿瘤反应的列线图的ROC曲线下面积(AUC),纳入CFP时(0.717)比未纳入CFP时(0.656)更好(p < 0.05)。

结论

CFP评分是预测LARC患者OS、DFS和NCRT疗效的更可靠标志物,该评分可明显提高列线图的预测效能。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/933e/8045186/ba767fed6009/12935_2021_1903_Fig6_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/933e/8045186/c962b1ab37cf/12935_2021_1903_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/933e/8045186/8f2fbad4fdef/12935_2021_1903_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/933e/8045186/f3635c128fec/12935_2021_1903_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/933e/8045186/066325861774/12935_2021_1903_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/933e/8045186/0c9341660361/12935_2021_1903_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/933e/8045186/ba767fed6009/12935_2021_1903_Fig6_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/933e/8045186/c962b1ab37cf/12935_2021_1903_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/933e/8045186/8f2fbad4fdef/12935_2021_1903_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/933e/8045186/f3635c128fec/12935_2021_1903_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/933e/8045186/066325861774/12935_2021_1903_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/933e/8045186/0c9341660361/12935_2021_1903_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/933e/8045186/ba767fed6009/12935_2021_1903_Fig6_HTML.jpg

相似文献

1
High CFP score indicates poor prognosis and chemoradiotherapy response in LARC patients.高CFP评分表明局部晚期直肠癌(LARC)患者预后不良且对放化疗反应不佳。
Cancer Cell Int. 2021 Apr 13;21(1):205. doi: 10.1186/s12935-021-01903-1.
2
Preoperative Fibrinogen-Albumin Ratio Index (FARI) is a Reliable Prognosis and Chemoradiotherapy Sensitivity Predictor in Locally Advanced Rectal Cancer Patients Undergoing Radical Surgery Following Neoadjuvant Chemoradiotherapy.术前纤维蛋白原-白蛋白比值指数(FARI)是接受新辅助放化疗后行根治性手术的局部晚期直肠癌患者可靠的预后及放化疗敏感性预测指标。
Cancer Manag Res. 2020 Sep 17;12:8555-8568. doi: 10.2147/CMAR.S273065. eCollection 2020.
3
Prognostic value of mesorectal package area in patients with locally advanced rectal cancer following neoadjuvant chemoradiotherapy: A retrospective cohort study.新辅助放化疗后局部晚期直肠癌患者中直肠系膜包绕面积的预后价值:一项回顾性队列研究
Front Oncol. 2022 Oct 3;12:941786. doi: 10.3389/fonc.2022.941786. eCollection 2022.
4
Fibrinogen-Albumin Ratio Index (FARI): A More Promising Inflammation-Based Prognostic Marker for Patients Undergoing Hepatectomy for Colorectal Liver Metastases.纤维蛋白原-白蛋白比值指数(FARI):一种用于预测结直肠癌肝转移患者行肝切除术预后的更有前途的炎症标志物。
Ann Surg Oncol. 2019 Oct;26(11):3682-3692. doi: 10.1245/s10434-019-07586-3. Epub 2019 Jul 1.
5
The preoperative geriatric nutritional risk index predicts long-term prognosis in elderly locally advanced rectal cancer patients: a two-center retrospective cohort study.术前老年营养风险指数可预测老年局部晚期直肠癌患者的长期预后:一项双中心回顾性队列研究。
Aging Clin Exp Res. 2023 Feb;35(2):311-321. doi: 10.1007/s40520-022-02297-4. Epub 2022 Nov 18.
6
Predictive value of indirect bilirubin before neoadjuvant chemoradiotherapy in evaluating prognosis of local advanced rectal cancer patients.新辅助放化疗前间接胆红素对局部晚期直肠癌患者预后评估的预测价值
World J Gastrointest Oncol. 2022 Nov 15;14(11):2224-2237. doi: 10.4251/wjgo.v14.i11.2224.
7
[Relationship between preoperative inflammatory indexes and prognosis of patients with rectal cancer and establishment of prognostic nomogram prediction model].[直肠癌患者术前炎症指标与预后的关系及预后列线图预测模型的建立]
Zhonghua Zhong Liu Za Zhi. 2022 May 23;44(5):402-409. doi: 10.3760/cma.j.cn112152-20200630-00612.
8
Predictive Value of the Neutrophil-Lymphocyte Ratio for Tumor Regression Grade and Prognosis of Local Advanced Rectal Cancer Patients Undergoing Neoadjuvant Chemoradiotherapy.中性粒细胞-淋巴细胞比值对接受新辅助放化疗的局部晚期直肠癌患者肿瘤退缩分级和预后的预测价值。
Technol Cancer Res Treat. 2023 Jan-Dec;22:15330338231202611. doi: 10.1177/15330338231202611.
9
Pretreatment Albumin-to-Fibrinogen Ratio Independently Predicts Chemotherapy Response and Prognosis in Patients with Locally Advanced Rectal Cancer Undergoing Total Mesorectal Excision After Neoadjuvant Chemoradiotherapy.新辅助放化疗后接受全直肠系膜切除术的局部晚期直肠癌患者,治疗前白蛋白与纤维蛋白原比值可独立预测化疗反应及预后。
Onco Targets Ther. 2020 Dec 23;13:13121-13130. doi: 10.2147/OTT.S288265. eCollection 2020.
10
Pretreatment Inflammatory-Nutritional Biomarkers Predict Responses to Neoadjuvant Chemoradiotherapy and Survival in Locally Advanced Rectal Cancer.治疗前炎症-营养生物标志物可预测局部晚期直肠癌新辅助放化疗的疗效及生存情况。
Front Oncol. 2021 Mar 17;11:639909. doi: 10.3389/fonc.2021.639909. eCollection 2021.

引用本文的文献

1
Evaluating Extended Field of View Imaging for Measuring Rectal Tumor Lowest Boundary to Anal Verge Distance via Transrectal Biplane Ultrasound.经直肠双平面超声评估扩大视野成像测量直肠肿瘤至肛门边缘距离的最低边界
Ultrasound Int Open. 2025 May 5;11:a25696939. doi: 10.1055/a-2569-6939. eCollection 2025.
2
Analysis of risk characteristics for early progression and late progression in locally advanced rectal cancer patients: a large population-based and validated study.局部进展期直肠癌患者早期进展和晚期进展风险特征分析:一项大型基于人群且经过验证的研究。
Support Care Cancer. 2024 May 11;32(6):340. doi: 10.1007/s00520-024-08546-8.
3

本文引用的文献

1
Raman-Enhanced Spectroscopy (RESpect) Probe for Childhood Non-Hodgkin Lymphoma.用于儿童非霍奇金淋巴瘤的拉曼增强光谱(RESpect)探头。
SciMed J. 2020 Mar;2(1):1-7. doi: 10.28991/scimedj-2020-0201-1.
2
Preoperative Fibrinogen-Albumin Ratio Index (FARI) is a Reliable Prognosis and Chemoradiotherapy Sensitivity Predictor in Locally Advanced Rectal Cancer Patients Undergoing Radical Surgery Following Neoadjuvant Chemoradiotherapy.术前纤维蛋白原-白蛋白比值指数(FARI)是接受新辅助放化疗后行根治性手术的局部晚期直肠癌患者可靠的预后及放化疗敏感性预测指标。
Cancer Manag Res. 2020 Sep 17;12:8555-8568. doi: 10.2147/CMAR.S273065. eCollection 2020.
3
Predictive Value of the Interaction between CEA and Hemoglobin in Neoadjuvant CCRT Outcomes in Rectal Cancer Patients.
癌胚抗原与血红蛋白的相互作用对直肠癌患者新辅助放化疗结局的预测价值
J Clin Med. 2023 Dec 14;12(24):7690. doi: 10.3390/jcm12247690.
4
The fibrinogen-albumin ratio as a novel prognostic factor for elderly patients with osteosarcoma.纤维蛋白原-白蛋白比值作为一种新的预后因素用于老年骨肉瘤患者。
Medicine (Baltimore). 2023 Sep 8;102(36):e34926. doi: 10.1097/MD.0000000000034926.
5
A boundary-guided transformer for measuring distance from rectal tumor to anal verge on magnetic resonance images.一种用于在磁共振图像上测量直肠肿瘤与肛缘距离的边界引导变压器。
Patterns (N Y). 2023 Mar 27;4(4):100711. doi: 10.1016/j.patter.2023.100711. eCollection 2023 Apr 14.
6
A novel prediction model for pathological complete response based on clinical and blood parameters in locally advanced rectal cancer.一种基于局部晚期直肠癌临床和血液参数的病理完全缓解的新型预测模型。
Front Oncol. 2022 Nov 23;12:932853. doi: 10.3389/fonc.2022.932853. eCollection 2022.
7
Biomarkers of Favorable vs. Unfavorable Responses in Locally Advanced Rectal Cancer Patients Receiving Neoadjuvant Concurrent Chemoradiotherapy.局部晚期直肠癌患者接受新辅助同期放化疗的有利和不利反应的生物标志物。
Cells. 2022 May 11;11(10):1611. doi: 10.3390/cells11101611.
8
Impact of Body Composition During Neoadjuvant Chemoradiotherapy on Complications, Survival and Tumor Response in Patients With Locally Advanced Rectal Cancer.新辅助放化疗期间身体组成对局部晚期直肠癌患者并发症、生存及肿瘤反应的影响
Front Nutr. 2022 Jan 27;9:796601. doi: 10.3389/fnut.2022.796601. eCollection 2022.
A Diagnostic Biopsy-Adapted Immunoscore Predicts Response to Neoadjuvant Treatment and Selects Patients with Rectal Cancer Eligible for a Watch-and-Wait Strategy.
一种诊断性活检适应的免疫评分可预测新辅助治疗反应,并选择适合观察等待策略的直肠癌患者。
Clin Cancer Res. 2020 Oct 1;26(19):5198-5207. doi: 10.1158/1078-0432.CCR-20-0337. Epub 2020 Jul 15.
4
Pro-Oxidant Enzymes, Redox Balance and Oxidative Damage to Proteins, Lipids and DNA in Colorectal Cancer Tissue. Is Oxidative Stress Dependent on Tumour Budding and Inflammatory Infiltration?促氧化酶、氧化还原平衡与结直肠癌组织中蛋白质、脂质和DNA的氧化损伤。氧化应激是否依赖于肿瘤芽生和炎症浸润?
Cancers (Basel). 2020 Jun 20;12(6):1636. doi: 10.3390/cancers12061636.
5
Serial circulating tumour DNA analysis for locally advanced rectal cancer treated with preoperative therapy: prediction of pathological response and postoperative recurrence.术前治疗局部晚期直肠癌的循环肿瘤 DNA 序列分析:预测病理反应和术后复发。
Br J Cancer. 2020 Sep;123(5):803-810. doi: 10.1038/s41416-020-0941-4. Epub 2020 Jun 22.
6
Prognostic Value of the Combination of CEA and Fibrinogen/Albumin Ratio in Resectable Gastric Cancer.癌胚抗原与纤维蛋白原/白蛋白比值联合检测在可切除胃癌中的预后价值
Cancer Manag Res. 2020 Apr 23;12:2767-2775. doi: 10.2147/CMAR.S246566. eCollection 2020.
7
Colorectal cancer statistics, 2020.2020 年结直肠癌统计数据。
CA Cancer J Clin. 2020 May;70(3):145-164. doi: 10.3322/caac.21601. Epub 2020 Mar 5.
8
Adjuvant Chemotherapy Does Not Improve Recurrence-Free Survival in Patients With Stage 2 or Stage 3 Rectal Cancer After Neoadjuvant Chemoradiotherapy and Total Mesorectal Excision.新辅助放化疗和全直肠系膜切除术治疗后,Ⅱ期或Ⅲ期直肠癌患者辅助化疗并不能改善无复发生存。
Dis Colon Rectum. 2020 Apr;63(4):427-440. doi: 10.1097/DCR.0000000000001558.
9
Prognostic impact of preoperatively elevated and postoperatively normalized carcinoembryonic antigen levels following curative resection of stage I-III rectal cancer.根治性切除 I-III 期直肠癌术后癌胚抗原水平升高和正常化对预后的影响。
Cancer Med. 2020 Jan;9(2):653-662. doi: 10.1002/cam4.2758. Epub 2019 Dec 4.
10
Antioxidant Barrier, Redox Status, and Oxidative Damage to Biomolecules in Patients with Colorectal Cancer. Can Malondialdehyde and Catalase Be Markers of Colorectal Cancer Advancement?抗氧化屏障、氧化还原状态和生物分子氧化损伤与结直肠癌患者。丙二醛和过氧化氢酶可否作为结直肠癌进展的标志物?
Biomolecules. 2019 Oct 22;9(10):637. doi: 10.3390/biom9100637.